Evotec To Use $25 Mil. Financing To Develop Drug Screening Services
Executive Summary
Evotec BioSystems will use its latest round of private financing to further develop its high-throughput drug screening technology and to fund internal drug discovery programs in the antiviral and antibacterial fields. The company also is planning development work on diagnostic applications of its technology.